KAYLA DEL RIO: Open Payments
NPI 1487060216 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,729 in 155 payments from 27 companies in 2025. Trend: 2023 $31,368 · 2024 $25,818 · 2025 $29,729
Speaker / faculty: $21,543Food & beverage: $4,165Travel & lodging: $2,478Consulting: $1,460Education: $84
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 64 | $27,105 |
| ViiV Healthcare Company | 31 | $708 |
| Madrigal Pharmaceuticals | 2 | $257 |
| Abbott Laboratories | 4 | $197 |
| ABBVIE INC. | 14 | $192 |
| Dexcom, Inc. | 2 | $144 |
| Eisai Inc. | 2 | $141 |
| GlaxoSmithKline, LLC. | 2 | $136 |
| ACADIA Pharmaceuticals Inc | 1 | $123 |
| Janssen Biotech, Inc. | 2 | $108 |
Products named: Biktarvy, Yeztugo, Descovy, CABENUVA, REZDIFFRA, FREESTYLE LIBRE 3, APRETUDE, Leqembi.
Industry payments across KS — which companies pay providers there.
